Disclaimer
Copyright 2025 by Soterius, Inc. All rights reserved. Soterius logo are trademarks or registered trademarks of Soterius in all jurisdictions. Other marks may be trademarks or registered trademarks of their respective owners. The information you see, hear or read on the pages within this presentation, as well as the presentation’s form and substance, are subject to copyright protection. In no event, may you use, distribute, copy, reproduce, modify, distort, or transmit the information or any of its elements, such as text, images or concepts, without the prior written permission of Soterius. No license or right pertaining to any of these trademarks shall be granted without the written permission of Soterius (and any of its global offices and/or affiliates). Soterius reserves the right to legally enforce any infringement of its intellectual property, copyright and trademark rights.
Any content presented herewith should only be considered for general informational purposes and should not be considered as specific to the requirements of any particular organisation or for any specific purpose. Soterius does not make any representations or warranties about the completeness, reliability, appropriateness, relevance, or accuracy of the content presented here.
Discover more
abinash kumar •
10 Min Read
Six Things I Keep Coming Back To in Clinical Signalling
The mechanics of signal detection are familiar enough. A disproportionality score crosses a threshold, a case series is reviewed,an action is taken. Underneath the mechanics sits the actual work: a…
Sep 28, 2026
abinash kumar •
10 Min Read
Governance and Accountability in AI-Enabled Pharmacovigilance
Governance and accountability are foundational to the use of artificial intelligence in pharmacovigilance. AI systems do not exist outside the pharmacovigilance system in which they are deployed. Decisions about their…
Apr 14, 2026
abinash kumar •
10 Min Read
Human Oversight in AI-Enabled Pharmacovigilance: What ‘HITL’ Actually Has to Mean
1. Why Human Oversight Is a Control, Not a Reassurance As artificial intelligence becomes embedded in pharmacovigilance workflows, the presence of a human reviewer is often assumed to be a…
Feb 20, 2026
